Allogene Therapeutics - 48 Year Dividend Yield History | ALLO

Historical dividend payout and yield for Allogene Therapeutics (ALLO) since 1971. The current TTM dividend payout for Allogene Therapeutics (ALLO) as of February 21, 2019 is $0.00. The current dividend yield for Allogene Therapeutics as of February 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.728B $0.000B
Allogene Therapeutics, Inc. is a biotechnology company. It develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. The company's product pipeline consists of UCART19, ALLO-501, ALLO-715, ALLO-819, CD70, DLL3 and ALLO-647 which are in clinical stage. Allogene Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29